Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study
Open Access
- 11 December 2007
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (3) , 457-463
- https://doi.org/10.1111/j.1538-7836.2007.02872.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Factor IXa Inhibitors as Novel AnticoagulantsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer TechnologyCirculation, 2006
- Oral Anticoagulants in DevelopmentDrugs, 2006
- Emerging anticoagulants for the treatment of venous thromboembolismThrombosis and Haemostasis, 2006
- RNA aptamers as reversible antagonists of coagulation factor IXaNature, 2002
- Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic StrokeStroke, 2002
- Selective anticoagulation with active site-blocked factor IXa suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Heparinless cardiopulmonary bypass with active-site blocked factor IXa: A preliminary study on the dogThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.Journal of Clinical Investigation, 1991
- Basic Mechanisms in Blood CoagulationAnnual Review of Biochemistry, 1975